July 2014 Newsletter

July 15, 2014:

Q1-2014 IOL Procedures Fall Short of Expectations

Slowdown mirrors disappointing quarters in refractive, retina, and glaucoma subspecialties due to weather conditions.

July 15, 2014:

Drug Firms Racing to Lower Taxes with Inversions

Gaming the US tax system has become a major strategy in increasing shareholder value.

July 15, 2014:

Weather Issues Impact Q1-2014 US Refractive Procedure Volumes

Other factors also contribute to depressed demand.

July 15, 2014:

Unusually Strong US Phacoemulsifier Sales Expected in 2014, 2015

Annual survey indicates that nearly a quarter of responding surgeons plan to buy a new phaco machine within a year.

July 15, 2014:

AMO Enters Market for Extended Depth of Focus IOLs

The company has received CE Marking in Europe for the TECNIS Symfony lens.

July 15, 2014:

Market Scope Expects Growth in the Retinal Pharmaceuticals Market to Moderate

Global revenues are expected to increase from roughly $7.9 billion in 2014 to more than 10.4 billion in 2019.

July 15, 2014:

Iluvien Gains Approval in Italy as FDA Decision Draws Nearer

Of the original European countries to which Alimera applied, Italy is the seventh and last to authorize the sustained-release corticosteroid implant for use in DME.

July 15, 2014:

France Votes to Allow Use of Avastin in Wet AMD Cases

It is the second European country to back reimbursement for off-label use of the cheaper Avastin as a cost-cutting measure.

July 15, 2014:

ThromboGenics to Remain Independent

The Belgium-based company will pursue a potential partnership for commercialization of Jetrea in the US.

July 15, 2014:

FDA Approves Ozurdex for Use in Some DME Patients

The implant delivers the glucocorticosteroid dexamethasone to the posterior segment of the eye.

July 15, 2014:

QLT to Merge with Auxilium Pharmaceuticals

Combined entity will be renamed New Auxilium.

July 15, 2014:

Europe Takes Another Step Toward Transparency

The Management Board of the European Medicines Agency (EMA) has adopted new rules on publishing clinical trial data.

July 15, 2014:

July 2014 News Briefs

Social media